preview

Osteoporosis Summary

Satisfactory Essays

In the new treatments of osteoporosis by Bente Langdahl. Langdahl states that medical studies are close to finding a way to keep bone density to remain the same without bones being easily fractured. All of the procedures that Langdahls article has attempted was an anabolic treatment. They just need to figure out why the antiresorptive is coupling in the cathepsin k and sclerosis. Once they can solve why the matrix is coupling and get it approve Langdahl believe that this will be two new valuable tools for people who have osteoporosis. In this article, Langdahl thinks that once they fix the matrix of the cathepsin K and the sclerosin from coupling this will be very helpful for the bone mass and bone volume. This is only a temporary solution until they can figure out the reason the two inhibitors are coupling. This formula with cathepsin K and sclerosin has proven …show more content…

These mice had a high bone mass of the vertebrae and long bones and increased cortical thickness. Which is a bone closed to patients with pycnodysostosis. The author decided that mice are not like humans because humans have proteases that can degrade collagen during skeletal development. They decide to try blosozumab and romosozumab. Blosozumab and romosozumab work great together they strongly stimulate bone formation during the first six months of the treatments. At the same time bone resorption is suppressed at the baseline levels then decreases the levels for the remaining time of the treatment. This formula is to help avoid fractures in osteoporosis patients. At this moment this treatment is being considered if measurable targets can be identified for osteoporosis treatment. This treatment raises two new questions. If this target can be defined. Should this target be reached? And how the target should be maintained once it has been reached? Because this would mean patients’ needs repeated courses of anabolic

Get Access